Here are the latest quarterly results of GLENMARK LIFE SCIENCES. For more details, see the GLENMARK LIFE SCIENCES financial fact sheet and GLENMARK LIFE SCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 5,407 | 6,213 | 5,785 | 5,954 | 5,728 | 5,366 | 5,886 | 5,069 | |
Other income | Rs m | 66 | 28 | 19 | 54 | 17 | 31 | 55 | 85 | |
Turnover | Rs m | 5,473 | 6,242 | 5,803 | 6,007 | 5,745 | 5,397 | 5,941 | 5,154 | |
Expenses | Rs m | 3,953 | 4,149 | 3,853 | 4,283 | 4,002 | 3,952 | 4,291 | 3,725 | |
Gross profit | Rs m | 1,455 | 2,064 | 1,932 | 1,671 | 1,726 | 1,414 | 1,595 | 1,344 | |
Depreciation | Rs m | 108 | 115 | 126 | 131 | 132 | 145 | 144 | 151 | |
Interest | Rs m | 2 | 1 | 4 | 4 | 4 | 4 | 4 | 3 | |
Profit before tax | Rs m | 1,411 | 1,976 | 1,820 | 1,589 | 1,607 | 1,297 | 1,502 | 1,275 | |
Tax | Rs m | 361 | 513 | 466 | 402 | 419 | 317 | 388 | 321 | |
Profit after tax | Rs m | 1,050 | 1,464 | 1,355 | 1,187 | 1,188 | 979 | 1,115 | 953 | |
Gross profit margin | % | 26.9 | 33.2 | 33.4 | 28.1 | 30.1 | 26.4 | 27.1 | 26.5 | |
Effective tax rate | % | 25.6 | 25.9 | 25.6 | 25.3 | 26.1 | 24.5 | 25.8 | 25.2 | |
Net profit margin | % | 19.4 | 23.6 | 23.4 | 19.9 | 20.7 | 18.3 | 18.9 | 18.8 | |
Diluted EPS | Rs | 8.6 | 11.9 | 11.1 | 9.7 | 9.7 | 8.0 | 9.1 | 7.8 | |
Diluted EPS (TTM) | Rs | 34.2 | 38.1 | 40.3 | 41.3 | 42.4 | 38.4 | 36.5 | 34.6 | |
Subscriber Feature |
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.